Arcutis Biotherapeutics Inc. (ARQT) at a glance

Arcutis Biotherapeutics Inc. (ARQT) is a mid-cap Healthcare company. It trades at $23.89, with a -0.6% profit margin and revenue growth of 60.1%. It does not pay a dividend. Vestovix scores it 49/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Safety (24/100). It carries above-market volatility, so expect larger swings.

Price

$23.89

Market cap

$3.05B

P/E ratio

n/a

Dividend yield

None

Beta

1.52

52-week range

$15.10 to $31.77